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The aim of upper airway (UA) evaluation in patients with
sleep-disordered breathing (SDB) is not only to gain a better
insight into the complex pathophysiology of UA collapse
but also to improve treatment success rates while prospec-
tively selecting the most appropriate therapeutic option for
the individual patient [1]. UA assessment in SDB patients is
often limited by the fact that the evaluation is static and/or
performed during wakefulness, possibly not representing the
actual dynamics of UA collapsibility during sleep, while
investigations of the UA during natural sleep remain time
and manpower consuming [1–3]. Drug-induced sleep
endoscopy (DISE) provides an alternative method of studying
the UA while performing a fiberoptic endoscopy during
sedation as pharmacologically induced with midazolam
and/or propofol [1–4]. DISE allows to determine the
pattern of UA narrowing and obstruction, as part of
the therapeutic decision-making process towards UA
surgery and/or oral appliance therapy in patients with
SDB as there is a high interest in the prospective
prediction of non-CPAP treatment outcome [2, 4, 5].
Recent studies have examined the validity as well as
the test–retest and interrater reliability of DISE [6–8].
DISE procedures, however, lack uniformity in the methods
used for the drug-induced sedation, while a consensus on
DISE classification systems has not been established [3–5, 9].
In this issue of Sleep and Breathing, Eichler and col-
leagues compared the treatment recommendations that
would be given after a clinical basic ENT examination
(CBE) with the recommended therapy after conducting a
DISE [10]. The results of the reported study indicate that
DISE had a relevant impact on the treatment recommenda-
tion, and, thus, could possibly change the success rates of
non-CPAP therapy in SDB patients [10].
Mandibular advancement device (MAD) treatment
represents the main non-CPAP therapy for patients with
SDB [11, 12]. A custom-made, titratable MAD has been
recommended [13–15]. Currently, there is no reliable way to
prospectively predict the outcome of MAD treatment in
the individual patient [11]. As in previous reports, Eichler
et al. have been using a simultaneous mandibular protrusion
maneuver during DISE to assess whether mandibular ad-
vancement leads to a visible enhancement of the UA dimen-
sions, as a possible predictor of successful MAD treatment
[3–5, 10]. In the reported study, a modified jaw thrust
maneuver (Esmarch) was performed, by closing the mouth
and lightly pushing forward the mandible on both sides [10].
This approach has the potential disadvantage of not ade-
quately accounting for the given thickness of a particular
MAD, whereas each oral appliance inherently causes a
certain amount of vertical mouth opening [16]. In addition,
similar to the mandibular protrusion maneuver as reported
by Johal et al., the Esmarch maneuver is not reproducible in
terms of the degree of mandibular advancement [3, 5, 10].
Recently, a novel approach using a custom-made simulation
bite in maximal comfortable protrusion during DISE has
been described for the prediction of the outcome with
MAD treatment [4]. This technique might at least offer
the advantage of performing a reproducible mandibular
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maneuver, also accounting for the given thickness of a
MAD, but does not take into account the titratable
aspect of the currently recommended titratable MAD
treatment neither.
Sleep surgery procedures are directed at specific collapsible
UA structures and, therefore, DISE may add to a proper
selection of a specific surgical procedure for an individual
patient [2, 10]. In the reported study the most frequent site of
UA obstruction visualized by DISE was the palatal level,
which is indeed in line with other recent reports [3]. For all
treatment sites, except for the treatment of the tonsils, a
statistically significant disagreement was noted as recom-
mended by CBE versus DISE. Interestingly, the treatment
recommendations towards tongue base interventions and
MAD treatment had the highest range of change based on
DISE as compared to CBE [10].
Eichler and colleagues have to be congratulated for this
well-designed study with two different ENT specialists
performing the CBE versus the DISE independently from
each other, while a third ENT specialist compared CBE with
DISE findings and recommendations towards the type of
non-CPAP treatment. The detailed description of the clinical
criteria used for the treatment recommendations based on
CBE and DISE certainly adds to the quality of this publica-
tion by Eichler et al. [10]. Based on the results of the
reported study, an improvement in success rates of non-
CPAP therapies for SDB due to DISE can be assumed.
The results of this study might suggest that DISE is most
relevant when considering tongue base surgery or MAD
therapy; and that DISE might turn out to provide less added
value for the identification of indications for the treatment of
the tonsils [10]. As discussed previously, a possible criticism
of the reported study is that a non-reproducible and non-
titratable mandibular protrusion maneuver has been per-
formed during DISE, also not accounting for vertical open-
ing while closing the mouth.
DISE is increasingly performed offering the possibility of
dynamic UA evaluation during artificial sleep as a promis-
ing technique to select the proper non-CPAP treatment for
patients with SDB. On the other hand, DISE has potential
limitations as a patient’s selection tool. First, DISE lacks a
uniform method of sedation (bolus versus target controlled
infusion; midazolam and/or propofol administration) [3–5,
10]. Secondly, many different DISE classification systems
have been introduced in literature, without consensus [3–5,
9]. Finally, the mandibular advancement maneuvers per-
formed during DISE lack reproducibility and standardiza-
tion up to this date. As a result, the future challenges, among
other research topics, are to outline a standardized method
of sedation, to identify a uniform DISE classification sys-
tem, and, to define a reproducible and titratable standard
mandibular advancement maneuver during DISE.
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